Patricia Clark, Rev. John Cardinal O’Hara, C.S.C., Professor of Biochemistry at the University of Notre Dame, has been awarded a $1.1 million, four-year grant from the W. M. Keck Foundation to develop an innovative approach to replicate in test tubes a universal component of protein folding within cells.
Dr. Timothy Wencewicz (Ph.D. '11), Assistant Professor of Chemistry at Washington University in St. Louis, is the recipient of a 2018 Sloan Research Fellowship.
Norman Dovichi, Grace-Rupley Professor of Chemistry and Biochemistry, has been named to The Analytical Scientist’s 2017 Power List for his contributions to genomics research.
Research completed at the University of Notre Dame that tracked the maturation of the frog oocyte to an egg, followed by fertilization and progression to the two-cell embryo, provides a valuable foundation for developmental biologists who study the earliest stages of animal development.
The Harper Cancer Research Institute (HCRI) has received a $300,000 Institutional Research Grant (IRG) from the American Cancer Society (ACS), which is a renewal of the IRG grant from 2014.
Two Notre Dame researchers—Martin Haenggi, Frank M. Freimann Professor of Electrical Engineering, and Prashant V. Kamat, Rev. John A. Zahm, C.S.C., Professor of Science—have been named to Clarivate Analytics’ 2017 Highly Cited Researchers list. Clarivate’s list identifies the scholars who published the most articles that are in the top 1 percent of the most-cited articles.
Senior biochemistry major Annemarie Leonard knew she wanted to become a doctor, but the undergraduate research she has done since the summer after her freshman year has further fueled her passion. It also led to her being named as a co-author on a paper about ovarian cancer, as well as an author of chapter in an upcoming book.
Professor Emeritus Robert Schuler, Department of Chemistry and Biochemistry, passed away Nov. 13 (Monday). He was 91.
“He was best known as a strong leader, maintaining high professional standards for his unit while maintaining his own very active research program and seeking closer ties with the department,” said Paul Helquist, professor and associate chair in the Department of Chemistry and Biochemistry.
Notre Dame will lead a National Nuclear Security Administration (NNSA) Actinide Center of Excellence to conduct research in actinide and nuclear chemistry. The NNSA’s Stewardship Sciences Academic Alliance program will provide $12.5 million for the center, which is tasked with prioritizing research that is important for Stockpile Stewardship—the certification that the nation’s nuclear weapons are secure and operational.
Marya Lieberman, professor of chemistry and biochemistry, was featured as a member of the Notre Dame All-Faculty Team on Oct. 28 during the football game against North Carolina State.
What started as a small event in 2014 among Notre Dame’s community of soft matter and polymer researchers, has now grown into an annual regional symposium that includes faculty presentations and student posters from four universities.
Research took precedence over relaxation for several College of Science students this summer who spent 10 weeks completing undergraduate research projects at MD Anderson Cancer Center in Houston, Texas.
Determining how proteins function on a molecular level is crucial to understanding the underlying basis for disease. Now scientists at the University of Notre Dame are one step closer to unraveling the mystery of how intrinsically disordered proteins work, according to new research published in Science.
The fourth-year doctoral student in the Department of Chemistry and Biochemistry is one of ten 2017 recipients of the high-profile Graduate Research Fellowship in STEM from the National Institute of Justice (NIJ).
Colorectal cancer patients may benefit by avoiding sweets for three days before chemotherapy and by taking a common antimalaria drug, according to new research by biochemistry doctoral student Monica Schroll.
Researchers at the Harper Cancer Research Institute, which is a collaboration between the University of Notre Dame and the Indiana University School of Medicine South Bend (IUSM-SB), are working with community partners to not only foster awareness of ovarian cancer, but to develop tests for early detection, create novel chemotherapies, and target the Holy Grail: A cure.
The University of Notre Dame’s Advanced Diagnostics & Therapeutics (AD&T) initiative announced the recipients of its 2017 Discovery Fund awards, which provide seed funding to some of the most creative ideas being developed by Notre Dame faculty and their collaborators in areas of biomedical, environmental, and behavioral health.